HUP0302255A3 - Sulfonamide derivatives, pharmaceutical compositions containing them and their use - Google Patents
Sulfonamide derivatives, pharmaceutical compositions containing them and their useInfo
- Publication number
- HUP0302255A3 HUP0302255A3 HU0302255A HUP0302255A HUP0302255A3 HU P0302255 A3 HUP0302255 A3 HU P0302255A3 HU 0302255 A HU0302255 A HU 0302255A HU P0302255 A HUP0302255 A HU P0302255A HU P0302255 A3 HUP0302255 A3 HU P0302255A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- sulfonamide derivatives
- sulfonamide
- derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20600300P | 2000-05-19 | 2000-05-19 | |
| PCT/US2001/011747 WO2001090057A1 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0302255A2 HUP0302255A2 (hu) | 2003-11-28 |
| HUP0302255A3 true HUP0302255A3 (en) | 2005-11-28 |
Family
ID=22764580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0302255A HUP0302255A3 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives, pharmaceutical compositions containing them and their use |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030225163A1 (hu) |
| EP (1) | EP1311474A1 (hu) |
| JP (1) | JP2003534316A (hu) |
| KR (1) | KR20030007644A (hu) |
| CN (1) | CN1429205A (hu) |
| AR (1) | AR035915A1 (hu) |
| AU (1) | AU2001259053A1 (hu) |
| BR (1) | BR0110874A (hu) |
| CA (1) | CA2409830A1 (hu) |
| CZ (1) | CZ20023797A3 (hu) |
| DZ (1) | DZ3343A1 (hu) |
| EA (1) | EA200201234A1 (hu) |
| EC (1) | ECSP014078A (hu) |
| HR (1) | HRP20020918A2 (hu) |
| HU (1) | HUP0302255A3 (hu) |
| IL (1) | IL152156A0 (hu) |
| MX (1) | MXPA02010020A (hu) |
| NO (1) | NO20025459L (hu) |
| PE (1) | PE20020052A1 (hu) |
| PL (1) | PL358180A1 (hu) |
| SK (1) | SK16312002A3 (hu) |
| SV (1) | SV2002000459A (hu) |
| WO (1) | WO2001090057A1 (hu) |
| ZA (1) | ZA200208749B (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6984756B2 (en) | 2000-05-19 | 2006-01-10 | Eli Lilly And Company | Process for preparing biphenyl compounds |
| ES2225558T3 (es) | 2000-06-13 | 2005-03-16 | Eli Lilly And Company | Derivados de sulfonamida. |
| EP1438036A2 (en) * | 2001-10-12 | 2004-07-21 | Eli Lilly And Company | Use of sulfonamide derivatives as pharmaceuticals compounds |
| WO2005013961A1 (en) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Combination therapy for treatment of cognitive disorders or psychoses |
| EP2102153A1 (en) * | 2006-12-11 | 2009-09-23 | Eli Lilly & Company | Ampa receptor potentiators |
| CA2915405A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000006537A1 (en) * | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
-
2001
- 2001-05-04 AU AU2001259053A patent/AU2001259053A1/en not_active Abandoned
- 2001-05-04 KR KR1020027015545A patent/KR20030007644A/ko not_active Application Discontinuation
- 2001-05-04 CZ CZ20023797A patent/CZ20023797A3/cs unknown
- 2001-05-04 BR BR0110874-3A patent/BR0110874A/pt not_active Application Discontinuation
- 2001-05-04 DZ DZ013343A patent/DZ3343A1/fr active
- 2001-05-04 WO PCT/US2001/011747 patent/WO2001090057A1/en not_active Application Discontinuation
- 2001-05-04 HU HU0302255A patent/HUP0302255A3/hu unknown
- 2001-05-04 MX MXPA02010020A patent/MXPA02010020A/es unknown
- 2001-05-04 US US10/258,159 patent/US20030225163A1/en not_active Abandoned
- 2001-05-04 PL PL01358180A patent/PL358180A1/xx not_active Application Discontinuation
- 2001-05-04 EP EP01932536A patent/EP1311474A1/en not_active Withdrawn
- 2001-05-04 SK SK1631-2002A patent/SK16312002A3/sk unknown
- 2001-05-04 IL IL15215601A patent/IL152156A0/xx unknown
- 2001-05-04 CN CN01809667A patent/CN1429205A/zh active Pending
- 2001-05-04 JP JP2001586247A patent/JP2003534316A/ja not_active Withdrawn
- 2001-05-04 CA CA002409830A patent/CA2409830A1/en not_active Abandoned
- 2001-05-04 EA EA200201234A patent/EA200201234A1/ru unknown
- 2001-05-18 EC EC2001004078A patent/ECSP014078A/es unknown
- 2001-05-18 SV SV2001000459A patent/SV2002000459A/es not_active Application Discontinuation
- 2001-05-18 AR ARP010102374A patent/AR035915A1/es unknown
- 2001-05-18 PE PE2001000451A patent/PE20020052A1/es not_active Application Discontinuation
-
2002
- 2002-10-29 ZA ZA200208749A patent/ZA200208749B/en unknown
- 2002-11-14 NO NO20025459A patent/NO20025459L/no not_active Application Discontinuation
- 2002-11-19 HR HR20020918A patent/HRP20020918A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20025459D0 (no) | 2002-11-14 |
| BR0110874A (pt) | 2003-02-11 |
| DZ3343A1 (fr) | 2001-11-29 |
| IL152156A0 (en) | 2003-05-29 |
| NO20025459L (no) | 2002-11-14 |
| PL358180A1 (en) | 2004-08-09 |
| HRP20020918A2 (en) | 2004-02-29 |
| CA2409830A1 (en) | 2001-11-29 |
| PE20020052A1 (es) | 2002-02-02 |
| CN1429205A (zh) | 2003-07-09 |
| EP1311474A1 (en) | 2003-05-21 |
| AU2001259053A1 (en) | 2001-12-03 |
| US20030225163A1 (en) | 2003-12-04 |
| JP2003534316A (ja) | 2003-11-18 |
| KR20030007644A (ko) | 2003-01-23 |
| EA200201234A1 (ru) | 2003-04-24 |
| MXPA02010020A (es) | 2003-02-12 |
| SV2002000459A (es) | 2002-07-03 |
| ZA200208749B (en) | 2004-01-30 |
| HUP0302255A2 (hu) | 2003-11-28 |
| AR035915A1 (es) | 2004-07-28 |
| ECSP014078A (es) | 2002-02-25 |
| CZ20023797A3 (cs) | 2003-04-16 |
| SK16312002A3 (sk) | 2003-05-02 |
| WO2001090057A1 (en) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL154965A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
| HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
| HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
| HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
| HUP0301722A3 (en) | Pyrimidine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0400784A3 (en) | Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them | |
| IL148876A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
| HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
| IL151209A0 (en) | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation | |
| HUP0303069A3 (en) | Imidazole derivatives, pharmaceutical compositions containing them and their use | |
| HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
| HUP0402566A3 (en) | C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them | |
| IL202633A0 (en) | Sulfonamide derivatives and pharmaceutical compositions containing the same | |
| HUP0400540A3 (en) | 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
| HUP0400551A2 (en) | Piperazine derivatives, their preparation and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
| HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
| HUP0303184A3 (en) | Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them | |
| IL154240A0 (en) | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |